国際学会招聘講演・発表

招聘講演・発表

2017年

招聘講演

  1. Ichikawa S:MR-Guided Focused Ultrasound (FUS) for Uterine Fibroids in Japan. Imaging in Hawaii, 2017. 3.21-24, Hawaii, USA.
  2. Ichikawa S:Diagnostic Imaging of Solid Lesions of the Pancreas (Except for Invasive Ductal Carcinoma). Imaging in Hawaii, 2017. 3.21-24, Hawaii, USA.
  3. Ichikawa S:MRI Interpretation of Liver Nodules in Cirrhosis Using LI-RADS. Imaging in Hawaii, 2017. 3.21-24, Hawaii, USA.
  4. Motosugi U:MRI in the Cirrhotic liver. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
  5. Onishi H:Interpretation and management of oligometastases. ESTRO 36th Annual Congress 2017 (European Society for Radiotherapy and Oncology), 2017. 5.5- 9, Vienna, Austria.
  6. Onishi H:Pain and gain of stereotactic body radiation therapy (SBRT). The 5th Japan-Taiwan Radiation Oncology Symposium, 2017. 5.20, Kobe.

 

発表

  1. Omiya Y, Motosugi U, Ichikawa S, Umeda T, Onishi H:Utility of uptake rate in the thyroid bed measured by 123I tracer study before 131I radioactive iodine therapy for papillary thyrold cartinoma to predict treatment outcome. European Congress of Radiology (ECR) 2017, 2017. 3.1-5, Vienna, Austria.
  2. Ichikawa S, Motosugi U, Oguri M, Onishi H:Magnetic resonance elastography for prediction of radiation-induced liver disease after stereotactic body radiation therapy. European Congress of Radiology (ECR) 2017, 2017. 3.1-5, Vienna, Austria.
  3. Funayama S, Motosugi U, Ichikawa S, Onishi H:Diagnosis of Liver Cirrhosis Using Morphological Score with Magnetic Resonance Laparoscopy. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
  4. Matsuda M, Ichikawa S, Motosugi U, Matsuda M, Onishi H:Gadoxetic acid-enhanced MRI findings as a risk of multicentric recurrence of hepatocellular carcinoma after hepatectomy. ISMRM 25th Annual Meeting & Exhibition 2017. 4.22-27, Hawaii, USA.
  5. Mori Y, Motosugi U, Shimizu T, Ichikawa S, Onishi H:Bayesian prediction for insufficient liver enhancement in gadoxetic acid-enhanced hepatobiliary phase imaging. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
  6. Ichikawa S, Motosugi U, Omiya Y, Onishi H:Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
  7. Omiya Y, Ichikawa S, Motosugi U, Onishi H:Magnetic resonance elastography for uterine fibroids. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
  8. Takamura T, Ueda R, Hori M, Irie R, Kamagata K, Suzuki M, Aoki S:The Utility of DTI and NODDI for Assessment of Disease Severity and in Predicting Postoperative Neuronal Recovery: An Atlas-based Tract Specific Study. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA. (『summa cum laude』受賞)
  9. Le Bihan D, Ichikawa S, Motosugi U:IVIM virtual MR elastography of the liver. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
  10. Komiyama T: The results of escalated stereotactic body radiation therapy for stage ⅠA non-small cell lung cancer. The 5th Japan-Taiwan Radiation Oncology Symposium, 2017. 5.20, Kobe.
  11. Matasuda M: Stereotactic body radiation therapy using CyberKnife for patients with hepatocellular carcinoma. The 5th Japan-Taiwan Radiation Oncology Symposium, 2017. 5.20, Kobe.

 

2016年

招聘講演

  1. Ichikawa S:Recent Updates of DWI including Non-monoexponential Methods. The 4th International Congress on MRI & 21th Annual Scientific Meeting of KSMRM, 2016. 3.25-26, Seoul, Korea.
  2. Motosugi U:MR elastography-Principle. The 4th International Congress on MRI & 21th Annual Scientific Meeting of KSMRM, 2016. 3.25-26, Seoul, Korea.
  3. Motosugi U:Liver MRI update. The 4th International Congress on MRI & 21th Annual Scientific Meeting of KSMRM, 2016. 3.25-26, Seoul, Korea.
  4. Motosugi U:MRI Charaterization of Lesions in the Cirrhotic Liver. ISMRM 24th Annual Meeting & Exhibition 2016. 5.7-13, Singapore.
  5. Onishi H:SBRT for Stage 1 NSCLC. 3rd International SBRT Symposium & Workshop, 2016. 6.21-25, Singapore.
  6. Onishi H:SBRT for various organs and its toxicity. 3rd International SBRT Symposium & Workshop, 2016. 6.21-25, Singapore.
  7. Motosugi U:Imaging for selection and prioritization of LT candidates with HCC: the Asian Perspective. The 16th Asian Oceanian Congress of Radiology (AOCR 2016), 2016. 8.18-21, Beijing, China.
  8. Ichikawa S:Quantitative MR imaging for diffusse liver disease. The 72nd Korean Congress of Radiology (KCR 2016), 2016. 9.21-23, Seoul, Korea.
  9. Motosugi U:Imaging for Selection and Prioritization of LT Candidates with HCC: The Asian Perspective. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
  10. Motosugi U:Hypovascular and Hypointense Nodule in Gadoxetic Acid-Enhanced Liver MRI: Outcome and Management. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
  11. Onishi H:SBRT for primary or oligometastatic lung cancer: current status and the future. 2016 Advanced Radiation Therapy Summit : Tiwan-Japan (ARTS-2016), 2016. 12.10, Taipei, Taiwan.

発表

  1. Ichikawa S:Magnetic resonance elastography as a predictor of response to treatment of magnetic resonance-guided focused ultrasound for uterine fibroids: a preliminary study, European Congress of Radiology (ECR) 2016, 2016. 3.2-6, Vienna, Austria.
  2. Ichikawa S, Motosugi U, Morisaka H, Enomoto N, Matsuda M, Fujii H, Onishi H:Intravoxel incoherent motion diffusion-weighted imaging is a better indicator of high grade hepatocellular carcinoma than conventional apparent diffusion coefficient. The 7th Asian-Pacific Topic Conference (APTC2016), 2016. 4.20, Tokyo. 
  3. Ichikawa S, Motosugi U, Wakayama T, Kakegawa T, Kumagai H, Onishi H:Improved detection of capsular enhancement in hepatocellular carcinoma using multiphasic hepatic arterial imaging and DIfferential Sub-sampling with Cartesian Ordering (DISCO) in gadoxetic acid-enhanced magnetic resonance imaging. ISMRM 24th Annual Meeting & Exhibition, 2016. 5.7-13, Singapore.
  4. Takamura T, Murata S, Kamagata K, Tsuruta K, Hori M, Suzuki M, Aoki S:Extensive White Matter Damage in Neuromyelitis Optica Assessed by Neurite Orientation Dispersion and Density Imaging: A Tact-Based Spatial Statistics study. ISMRM 24th Annual Meeting & Exhibition 2016. 5.7-13, Singapore.
  5. Funayama S, Marino K, Nonaka H, Aoki S, Komiyama T, Kuriyama K, Onishi H:Stereotactic Body Radiation Therapy for Primary Lesion of Renal Cell Carcinoma. The 4th Taiwan-Japan Radiation Oncology Symposium, 2016. 6. 4, Taipei, Taiwan.
  6. Matsuda M, Onishi H, Komiyama T, Kuriyama K, Satani K, Takahashi H:Stereotactic Body Radiation Therapy for Lymph Node Metastases. The 4th Taiwan-Japan Radiation Oncology Symposium, 2016. 6. 4, Taipei, Taiwan.
  7. Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB:Respiratory motion artifact during arterial phase imaging with gadoxetic acid: a study at 2 sites in dirrerent continents. ESGAR 2016 (European Society of Gastrointestinal and Abdominal Radiology), 2016. 6.14-17, Prague, Czech Republic.
  8. Ichikawa S, Motosugi U, Hernando D, Morisaka H, Onishi H:Comparing the results of intravoxel incoherent motion diffusion-weighted imaging calculated by different estimation methods: discrimination of histological grade of HCC. ESGAR 2016 (European Society of Gastrointestinal and Abdominal Radiology), 2016. 6.14-17, Prague, Czech Republic.
  9. Onishi H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nomiya T, Uno T, Takanaka T, Takeda A, Kato N, Nakata K, Ogawa K:Excellent survival!-multi-institutional study of stereotactic body radiotherapy for medically operable and young (70 years old or younger) patients with stage I non-small cell lung cancer. American Society for Radiation Oncology 58th Annual Meeting (ASTRO), 2016. 9.25-28, Boston, USA.
  10. Ichikawa S, Motosugi U, wakayama T, Onishi H:Risk Assessment for Hepatocellular Carcinoma by Using Magnetic Resonance Elastography during Follow-up. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
  11. Shimizu T, Motosugi U, Ichikawa S, Onishi H:Assessing the Risk of Developing Hepatocellular Carcinoma by Gadoxetic Acid-enhanced MRI and MR Elastography: A Prospective Study. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
  12. Shimizu T, Motosugi U, Sano K, Ichikawa S, Onishi H:Long-term Observation of Hypovascular Hypointense Nodules (HHNs) on Gadoxetic Acid-enhanced MRI. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
  13. Omiya Y, Ichikawa S, Motosugi U, Onishi H:Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Predicts Better Prognosis after Surgical Resection in Patients with Pancreatic Cancer. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
  14. Onishi H, Shioyama Y, Matsumoto K, Takayama K, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K:Excellent Survival Achieved by Stereotactic Body Radiotherapy for Medically Operable and Young (< 75 Years) Patients with Stage I Lung Cancer. 17th IASLC World Conference on Lung Cancer, 2016. 12.4-7, Vienna, Austria.
  15. Komiyama T, Kuriyama K, Marino K, Aoki S, Araya M, Onishi H:Primary Results of Dose Escalated Stereotactic Body Radiotherapy for Stage IA Non-Small Cell Lung Cancer. 17th IASLC World Conference on Lung Cancer, 2016. 12. 4- 7, Vienna, Austria.

 

2015年

招聘講演

  1. Ichikawa S:Clinical Application of EOB (Eovist)-enhanced MR. IMAGING IN HAWAII, 2015. 3.23-26, Hawaii, USA.
  2. Ichikawa S:CT and MR Protocols for Pancreatic Tumors. IMAGING IN HAWAII, 2015. 3.23-26, Hawaii, USA.
  3. Onishi H:Lung SBRT in the next 10 years; lessons learnt from the JCOG 0403. Radiology Asia 2015, 2015. 5.14-16, Singapore.
  4. Onishi H:Dose escalation in unresectable Stage 3 NSCLC. Where do we go from here. Radiology Asia 2015, 2015. 5.14-16, Singapore.
  5. Onishi H:Pneumonitis in lung radiotherapy: Prevention and Diagnosis. Radiology Asia 2015, 2015. 5.14-16, Singapore.
  6. Onishi H:Lung Oligometastases: Results of SBRT. Radiology Asia 2015, 2015. 5.14-16, Singapore.
  7. Onishi H:A New Horizon of Radiotherapy Expanded by Hypofractionated Irradiation. ICRR 2015 (15th International Congress of Radiation Research) 2015. 5.25-29, Kyoto.
  8. Motosugi U:Update on Contrast Agents for Body Imaging: Hepatobiliary Contrast Agents. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
  9. Onishi H:Important Points of Treatment-related Toxicity caused by Stereotactic Body Radiation Therapy. ISRS 2015 (12th International Stereotactic Radiosurgery Society Congress), 2015. 6.7-11, Yokohama.
  10. Onishi H:For the Future: Expanding Role of SBRT for Not Only Medically Inoperable or High-risk Operable But Also Low-risk Operable Patients. The 3rd Japan-Taiwan Radiation Oncology Symposium, 2015. 6.27, Fujiyosida. (Organizer Speech)
  11. Onishi H:Expanding Role of Stereotactic Body Radiotherapy and The Importance of Respiration Motion Control. Lecture of Prof. Onishi “Stereotactic Body Radiotherapy”, 2015. 8.14, Taipei Veterans General Hospital (台北栄民総病院).
  12. Onishi H:Expanding Role of Stereotactic Body Radiotherapy and The Importance of Respiration Motion Control. Lecture of Prof. Onishi “Stereotactic Body Radiotherapy”, 2015. 8.14, Shin Kong Wu Ho-Su Memorial Hospital (新光呉火獅記念病院).
  13. Onishi H:Clinical efficiency of stereotactic ablative radiotherapy for lung cancer. The 2015 Symposium on the Latest Advances of Radiation Oncology, Chenzhou, 2015. 9. 5- 6, Hunan, Chaina.

発表

  1. Onishi H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Nomiya T, Katoh N, Nakata K, Uno T, Murakami N:Japanese Multi-institutional Study of SBRT for More than 2000 Patients with Stage I Non-small Cell Lung Cancer or Pulmonary Oligometastases. ICRR 2015 (15th International Congress of Radiation Research), 2015. 5.25-29, Kyoto. 〔JRR Award at ICRR 2015〕
  2. Komiyama T, Kuriyama K, Muramatsu J, Oguri M, Nonaka H, Chen Z, Sano N, Asizawa K, Onishi H:High Dose Concurrent Chemoradiotharapy for Locally Advanced, Post Operative Residual or Recurrent Non-small-cell Lung Cancer. ICRR 2015 (15th International Congress of Radiation Research), 2015. 5.25-29, Kyoto.  
  3. Oguri M, Kuriyama K, Komiyama T, Nonaka H, Chen Z, Onishi H:Helical Tomotherapy in Radiotherapy for Prostate Cancer-A Dosimetric Comparison of Static Jaw and TomoEDGE Dynamic Jaw Delivery. ICRR 2015 (15th International Congress of Radiation Research), 2015. 5.25-29, Kyoto.  
  4. Araki T, Okada H, Tominaga R, Onishi H:Therapeutic efficacy and liver function change by embolization of portosystemic venous shunt for hepatic encephalopathy without or with liver cirrhosis. 44th JSIR, ISIR & APCIO 2015, 2015. 5.28-30, Miyazaki.
  5. Araki T, Okada H, Tominaga R, Onishi H:Endovascular marking for abdominal radiotherapy using CyberKnife: second report. 44th JSIR, ISIR & APCIO 2015, 2015. 5.28-30, Miyazaki.
  6. Okada H, Araki T, Onishi H:Treatment outcome of selective arterial infusion chemotherapy with radiotherapy for bladder cancer in our hospital. 44th JSIR, ISIR & APCIO 2015, 2015. 5.28-30, Miyazaki.  
  7. Motosugi U, Bannas P, Bookwalter CA, Reeder SB:Prospective Assessment of Transient Dyspnea and Arterial Oxygen Saturation After Injection of Gadoxetetic Acid in a Large Patient Cohort. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
  8. Motosugi U, Bannas P, Roldan-Alzate A, Kelly SG, Said A, Wieben O, Reeder SB:4D-Flow MRI for Risk Stratification of Gastroesophageal Varices in Cirrhotic Patiants. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
  9. Motosugi U, Hernando D, Bannas P, Reeder SB:High SNR Improves the Repeatability of Proton Density Fat Fraction Measurements in the Liver. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
  10. Motosugi U, Bannas P, Hernando D, Rahimi MS, Holmes JH, Reeder SB:Intra-Individual Crossover Comparison of Dose of Gadoxetic Acid for Liver MRI: Parameter Optimization and Quantitative Relaxometry in Normal Volunteers. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.  
  11. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Nakano M, Onishi H:Distinguishing Early and Progressed HCC Using Texture Analysis Using Gadoxetic Acid-Enhanced Hepatobiliary Phase Image. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.  
  12. Takamura T, Motosugi U, Ichikawa S, Sano K, Morisaka H, Ichikawa T, Enomoto N, Onishi H:The Usefulness of Magnetic Resonance Elastography in Predicting Progression of Cirrhosis from Child-Pugh Class a to B. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6.5, Toronto, Canada.〔Magna Cum Laude Merit Award〕 
  13. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Onishi H:A study of validation and reliability for liver stiffness measurement with magnetic resonance elastography for staging hepatic fibrosis in patients with chronic hepatitis B. ESGAR 2015 (European Society of Gastrointestinal and Abdominal Radiology), 2015. 6.9-12, Paris, France.
  14. Komiyama T, Kuriyama K, Muramatsu J, Oguri M, Nonaka H, Chen Z, Sano N, Ashizawa K, Onishi H:Relationship Between Patterns of Failure and Cause of Death after Stereotactic Body Radiotherapy for Stage ⅠA Non-small-cell Lung Cancer. The 3rd Japan-Taiwan Radiation Oncology Symposium, 2015. 6.28, Fujiyosida.
  15. Onishi H:Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for 678 Medically Operable Patients With Stage I Non-Small Cell Lung Cancer. American Society for Radiation Oncology 57th Annual Meeting (ASTRO), 2015. 10.18-21, San Antonio, USA.
  16. Onishi H:Dose escalation study of stereotactic body radiotherapy (SBRT) for peripheral T2N0M0 non-small cell lung cancer (NSCLC) with PTV ≥ 100 cc: Japan Clinical Oncology Group Study (JCOG0702). American Society for Radiation Oncology 57th Annual Meeting (ASTRO), 2015. 10.18-21, San Antonio, USA.
  17. Shimizu T, Sano K, Ichikawa T, Motosugi U, Morisaka H, Ichikawa S, Onishi H, Matsuda M, Fujii H:Hepatocellular Carcinoma without Gadoxetic Acid Uptake on Preoperative MR Imaging: An Important Prognostic Risk Factor after Liver Resection. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  18. Motosugi U, Yamaguchi H, Morisaka H:Solid Pseudopapillary Neoplasm of the Pancreas: Minimum Knowledge in Pathology to Understand Variation of Imaging Features. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  19. Sano K, Ichikawa T, Shimizu T, Motosugi U, Morisaka H, Ichikawa S, Onishi H, Matsuda M, Fujii H:Presence of Hypovascular and Hypointense Nodules on Preoperative Gadoxetic Acid-enhanced MR Imaging: An Important Risk Factor for Recurrence after Liver Resection for Hypervascular Hepatocellular Carcinoma. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  20. Sano K, Ichikawa T, Motosugi U, Morisaka H, Ichikawa S, Matsuda M, Onishi H, Fujii H:Early Hepatocellular Carcinoma: Clinical Features, Impact, and Radiologic-pathologic Correlation. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  21. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Onishi H:Intravoxel Incoherent Motion Diffusion-weighted Imaging is a Better Indicator of High Grade Hepatocellular Carcinoma Than Conventional Apparent Diffusion Coefficient. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  22. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Onishi H:Noninvasive Hepatic Fibrosis Staging Using Magnetic Resonance Elastography: The Usefulness of the Bayesian Prediction Method. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  23. Morisaka H, Ichikawa T, Kondo F, Sano K, Ichikawa S, Motosugi U, Onishi H:Combined Hepatocellular and Cholangiocarcinoma of the Liver: Minimum Knowledge of Pathology and Variation in Imaging Features. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
  24. Nonaka H:Stereotactic Body Radiation Therapy for Primary Lesion of Renal Cell Carcinoma. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.

2014年

招聘講演

  1. Onishi H:Stereotactic Body Radiotherapy for stage Ⅰ non- small cell lung cancer-Japanese status. 1st GI-CoRE Medical Science and Engineering Symposium~Hokkaido Univ. and Stanford Univ. Joint Symposium~, 2014. 2.23, Sapporo.
  2. Onishi H:Latest advances in SBRT for non-small-cell lung cancer. Asian Oncology Summit 2014, 2014. 4.11-13, Kuala Lumpur, Malaysia.
  3. Onishi H:Stereotactic Ablative Body Radiotherapy (SABR) for Various Disease Status. 11th International Conferance of the Asian Clinical Oncology Society in conjuction with the 19th Taiwan Joint Cancer Conference, 2014. 5.2-4, Taipei, Taiwan.
  4. Motosugi U:Diffusion-weighted imaging of hepatic tumors: current knowledge and update (Joint Symposium with JRS). The 70th Korean Congress of Radiology And Annual Delegate Meeting of The Korean Society of Radiology (KCR 2014), 2014. 10. 8-11, Seoul, Korea.

発表

  1. Ichikawa S, Motosug U, Morisaka H, Sano K, Ichikawa T:Intravoxel incoherent motion diffusion-weighetd imaging for staging for hepatic fibrosis. European Congress of Radiology (ECR) 2014, 2014. 3.6-10, Vienna, Austria.
  2. Omiya Y, Motosugi U, Sano K, Morisaka H, Ichikawa S, Matsuda M, Fujii H, Ichikawa T:The relationship of vascular invasion and signal intensity of hepatocellular carcinomas on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging. European Congress of Radiology (ECR) 2014, 2014. 3.6-10, Vienna, Austria.
  3. Motosugi U, Hernando D, Bannas P, Holmes JH, Wang K, Simakawa A, Iwadate Y, Taviani V, Reeder SB:Free-Breathing Quantification of Liver Proton Density Fat-Fraction. Joint Annual Meeting ISMRM – ESMRMB, 2014. 5.10-16, Milano, Italy.
  4. Ichikawa S, Motosugi U, Shimizu T, Morisaka H, Sano K, Ichikawa T, Kakegawa T, Ikenaga S, Kumagai H, Onishi H:Magnetic Resonance Queckenstedt’s Test: A Preliminary Experience. Joint Annual Meeting ISMRM – ESMRMB, 2014. 5.10-16, Milano, Italy.
  5. Araki T:Angiographic Anatomy of the Celiac Trunk. The 4th Mongolian-Japanese Joint Radiological International Symposium – 2014, 2014. 7.4-8, Ulan Bator, Mongol.
  6. Onishi H, Matsumoto Y, Miyakawa A, Yamashita H, Nomiya T, Niibe Y, Nakata K, Kuriyama K, Komiyama T, Marino K, Aoki S, Maehata Y, Araya M, Saito R, Tominaga L, Oguri M, Watanabe I, Nonaka H, Sano N:Japanese Multi-Institutional Study of Stereotactic Boey Radiation Therapy for Totally 380 Patients With Lung Metastases. American Society for Radiation Oncology 56th Annual Meeting (ASTRO), 2014. 9.14-17, San Francisco, USA.
  7. Oguri M, Onishi H, Saitou A, Kuriyama K, Komiyama T, Tominaga L, Nonaka H, Omiya Y:The Factors which Influence Acute Exacerbation on Patients Receiving Stereotactic Body Radiation Therapy for Lung Cancers with “Interstitial Change”. American Society for Radiation Oncology 56th Annual Meeting (ASTRO), 2014. 9.14-17, San Francisco, USA.
  8. Nonaka H, Onishi H, Ozaki M, Tominaga L, Kuriyama K, Komiyama T, Oguri M:Re-stereotactic body radiotherapy (SBRT) for local recurrence of lung cancer previously treated with SBRT. American Society for Radiation Oncology 56th Annual Meeting (ASTRO), 2014. 9.14-17, San Francisco, USA.
  9. Satoh Y, Nambu A, Onishi H:Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. EANM ’14 27th Annual Congress of the European Association of Nuclear Medicine 2014. 10.18-22, Gothenburg, Sweden.
  10. Onishi H, Matsumoto Y, Miyakawa A, Yamashita H, Nomiya T, Niibe Y, Nakata K, Kuriyama K, Komiyama T, Marino K, Aoki S, Maehata Y, Araya M, Saito R, Tominaga L, Oguri M, Wtanabe I, Nonaka H, Sano N:Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for Totally 380 Patients With Lung Metastases. 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, 2014. 10.30-11. 1, Chicago, USA.
  11. Sano K, Motosugi U, Ichikawa T, Ichikawa S, Morisaka H, Onohara K, Takamura T, Onishi H:The Outcome of Hypovascular and Hypointense Nodules on Hepatocyte-phase Gadoxetic Acid-enhanced Magnetic Resonance Imaging; When Does It become a Conventional HCC?: 5 Years’ Experience. The 100th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2014. 11.30-12. 5, Chicago, USA.

2013年

招聘講演

  1. Araki T:Angiographic Anatomy of the Celiac Trunk. The 3rd Mongolian-Japanese Joint Radiological International Symposium – 2013, 2013. 7.7-9, Ulan Bator, Mongol.
  2. Onishi H:SABR For Early Stage Lung Cancer And Pulmonary Oligometastases(WCLC:世界肺癌学会). IASLC 15th World Conference on Lung Cancer, 2013. 10.27-30, Sydney, Australia.

発表

  1. Motosugi U, Takamura T, Ichikawa T, Sano K, Morisaka H, Ichikawa S, Araki T:MR elastography for predicting progression of cirrhosis. European Congress of Radiology (ECR) 2013, 2013. 3.7-11, Vienna, Austria.
  2. Ichikawa S, Motosgui U, Ichikawa T, Sano K, Morisaka H, Araki T:Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. European Congress of Radiology (ECR) 2013, 2013. 3.7-11, Vienna, Austria.
  3. Motosugi U, Wakayama T, Ichikawa T, Araki T, Kakite S, Dyvorne H:Comparing the results of intravoxel incoherent motion diffusion-weighted imaging calculated by different estimation methods. The 21st Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2013. 4.20-26, Salt Lake City, USA.
  4. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Ikenaga S, Kumagai H, Araki T:Magnetic Resonance Elastography in the Liver – Comparison between spin-echo echo-planar-imaging and gradient-echo sequence – The 21st Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2013. 4.20-26, Salt Lake City, USA.
  5. Onishi H:Stereotactic Radiotherapy for early stage lung cancer. Japan-Taiwan Conference on High Precision Radiotherapy, 2013. 8. 3, Tokyo.
  6. Onishi H, Shioyama Y, Matsumoto K, Takayama K, Matsuo Y, Miyakawa A:Japanese multi-institutional study of stereotactic body radiotherapy for more than 2000 patients with stage I non-small cell lung cancer. American Society for Radiation Oncology 55th Annual Meeting (ASTRO), 2013. 9.22-25, Atlanta, USA.
  7. Oguri M, Onishi H:Severe radiation pnemonitis after stereotactic radiotheraphy for patients with stage Ⅰ non-small cell lung cancer accompanying pulmonary fibrosisi. American Society for Radiation Oncology 55th Annual Meeting (ASTRO), 2013. 9.22-25, Atlanta, USA.
  8. Motosugi U, Sano K, Morisaka H, Ichikawa S, Ichikawa T:Simply Combine the Results of Multiple Elastographies and Serum Fibrosis Markers Using Bayesian Prediction for Noninvasive Liver Fibrosis Staging. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
  9. Sano K, Motosugi U, Morisaka H, Ichikawa S, Ichikawa T:Clinical Features of Hepatocellular Carcinoma Showing lsointense or Hyperintense on Hepatocyte-phase of Gadoxetic Acid-enhanced Magnetic Resonance Imaging; Radiologic-pathologic Correlation in Surgically Resected Cases. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
  10. Morisaka H, Motosugi U, Ichikawa S, Sano K, Satoshi I, Nakazawa T, Ichikawa T:Liver Fibrosis Staging: Magnetic Resonance Elastography Is Better than Liver Biopsy. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
  11. Ichikawa S, Motosugi U, Sano K, Morisaka H, Ichikawa T:Noninvasive Assessment of Hepatic Fibrosis by Liver Stiffness Measurement: Comparison of MR Elastography and Ultrasound Transient Elastography. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
  12. Ichikawa S, Motosugi U, Imaizumi M, Sano K, Morisaka H, Ichikawa T:CT Venography with Dual Energy CT: Dose Reduction of Contrast Material with Low Tube Voltage. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
  13. Takamura T, Ichikawa S, Motosugi U, Sano K, Morisaka H, Ichikawa T:The Activity Grade of Hepatitis Affects Liver Stiffness Measured Using MR Elastography. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.

2012年

招聘講演

  1. Motosugi U:MR Elastography of the Liver. The 17th Annual Scientific Meeting of Korean Society of Magnetic Resonance in Medicine, KSMRM-JSMRM joint symposium, 2012. 3.31-4.1, Incheon, Korea.

発表

  1. Sano K, Motosugi U, Morisaka H, Sou H, Ichikawa T, Araki T:Multi-organ perfusion CT in the abdomen using a 320-detector row scanner: Preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients. European Congress of Radiology (ECR) 2012, 2012. 3.1-5, Vienna, Austria.
  2. Motosugi U, Ichikawa T, Koshiishi T, Sano K, Muhi A, Morisaka H, Araki T:Liver Stiffness Determined by MR Elastography as a Biomarker for Predicting HCC Development in Patients with Chronic Liver Disease: preliminary case-control study. European Congress of Radiology (ECR) 2012, 2012. 3.1-5, Vienna, Austria.
  3. Ichikawa S, Motosugi U, Ichikawa T, Watanabe I, Morisaka H, Sano K, Araki T:Intravoxel incoherent motion imaging of the liver: Which affects more on apparent diffusion coefficient changes of cirrhosis and liver lesions, D or D*? The 20th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2012. 5.5-11, Melbourne, Australia.
  4. Venkatesh SK, Motosugi U, Wang G, Ichikawa T, Araki T, Lim SG, Wee A:Magnetic Resonance Elastography of Liver for Evaluation of Liver Fibrosis in Chronic Viral Hepatitis B and C in Asians: A Two Centre’s Experience. The 20th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2012. 5.5-11, Melbourne, Australia.
  5. Araki T, Okada H, Sakamoto H, Motosugi U, Araki T:Abdominal press method for the right adrenal venous movement by breathing in adrenal venous sampling. APCCVIR 2012 JSIR & ISIR, 2012. 5.30-6.2, Kobe.
  6. Araki T, Okada H, Motosugi U, Araki T:Angiographic anatomy of the left inferior phrenic vein in patients with normal liver -For balloon-occluded retrograde transvenous obliteration-. APCCVIR 2012 JSIR & ISIR, 2012. 5.30-6.2, Kobe.
  7. Okada H, Araki T, Araki T:NBCA embolization under blood-flow control with temporary balloon occlusion. APCCVIR 2012 JSIR & ISIR, 2012. 5.30-6.2, Kobe.
  8. Onishi H:Stereotactic Body Radiotherapy in 95 Patients With Lung Tumors Composed of Ground-glass Opacity (GGO) : Results of a Retrospective Multicenter study. American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
  9. Maehata Y, Onishi H, Kuriyama K, Tominaga L, Watanabe I, Oguri M, Araki T:What is the Cause of Immune Suppression in Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer? American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
  10. Oguri M, Onishi H, Nambu A, Kuriyama K, Maehata Y, Tominaga L, Araki T:Rib Fractures after Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer. American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
  11. Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D:Primary Central Nervous System Lymphoma (PCNSL) treated by radiation therapy: a nationwide survey of 2005-2009 patients and comparison with 1985-2004 data. American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
  12. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kunieda E, Ishikura S:Stereotactic body radiation therapy for T1NOMO non-small cell lung cancer:first report for inoperable population of a phase trial by Jaran Clinical Oncology Group (JCOG 0403). American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
  13. Motosugi U, Ichikawa T, Okada M, Kondo H, Sou H, Murakami T, Kanematsu M, Hatcho A, Yoshikawa S, Awai K, Yoshimitsu K, Yamashita Y:Recommended Iodine Dose for Hepatic Arterial-dominant Phase CT Images of the Liver for Visualizing Hypervascular Hepatocellular Carcinoma (HCC): Multicenter Prospective Study in 91 Community Hospitals in Japan. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
  14. Sano K, Motosugi U, Ichikawa T, Morisaka H, Ichikawa S, Araki T:The Outcome of Hypovascular Nodules Showing Hyperintense on Hepatocyte-Phase of Gadoxetic Acid-enhanced Magnetic Resonance Imaging: When Does It Become a Conventional HCC? 4 Years Follow-up Study. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
  15. Ichikawa S, Motosugi U, Ichikawa T, Morisaka H, Sano K, Araki T:Was This HCC Able to Be Seen on Previous Gadoxetic Acid-enhanced MR Images? A Retrospective Review of Previous MR Images in Patients with Hypervascular HCC. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
  16. Morisaka H, Motosugi U, Ichikawa T, Sano K, Ichikawa S, Araki T:Functional Abdominal MR Imaging for Prediction of Gastro-Esophageal Varices in Chronic Liver Disease Patients: Comparison with Liver and Spleen MR Elastography and Portal Vein Phase-Contrast MR Flow Measurements. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
  17. Takamura T, Ichikawa S, Motosugi U, Ichikawa T, Morisaka H, Sano K, Araki T:Use of MR Elastography of the Liver for Evaluating Hepatic Fabrosis in Hepatitis C Patients. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.

2011年

招聘講演

  1. Motosugi U:Multiparametric evalution of Abdominal MRI. Korean Society of Abdominal Radiology-GE Healthcare Grand Symposium(Session), 2011. 1, Seoul, Korea.
  2. Ichikawa T:Differentiation of Early HCC from DN by EOB-MRI: Japanese Perspective. The 2nd Asia- Pacific Primary Liver Cancer Expert Meeting, 2011. 7.1-3, Osaka.

発表

  1. Motosugi U, Ichikawa T, Sou H, Sano K, Muhi A, Araki T:Effects of gadoxetic acid on liver stiffness measurement by using magnetic resonance elastography. European Congress of Radiology (ECR) 2011, 2011. 3.3-7, Vienna, Austria.
  2. Morisaka H, Motosugi U, Ichikawa T, Sou H, Araki T:Gadoxetic acid-enhanced magnetic resonance imaging for evaluation of pancreatic adenocarcinoma and liver metastasis. European Congress of Radiology (ECR) 2011, 2011. 3.3-7, Vienna, Austria.
  3. Motosugi U, Ichikawa T, Sou H, Muhi A, Amemiya F, Enomoto N, Araki T:Cross-validation of MR elastography and ultrasound transient elastography in liver stiffness measurement. European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 2011, 2011. 5.21-24, Venice, Italy.
  4. Onishi H, Sato Y, Nambu A:Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. American Society for Radiation Oncology 53rd Annual Meeting (ASTRO), 2011. 10.2-6, Miami, USA.
  5. Maehata Y, Onishi H, Kuriyama K, Aoki S, Araya M, Saito R, Oguri M, Araki T:Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer Causes Immune Suppression. American Society for Radiation Oncology 53rd Annual Meeting (ASTRO), 2011. 10.2-6, Miami, USA.
  6. Nambu A, Zach J, Lynch DA, Schroeder JD, Jin G, Schnell C, et al:Correlation between Diffusion Capacity for Carbon Monoxide (DLCO) and Quantitative CT in Smokers in a Single Institution Study. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  7. Araki T, Okada H, Araki T:Enhancement of Ascites during Abdominal Vascular Interventions with CT-IVR Combination System. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  8. Motosugi U, Muhi A, Ichikawa T, Sano K, Morisaka H, Sou H, Araki T:MR Elastograpy Can Predict an Insufficient Liver Enhancement on Gadoxetic Acid-enhanced Hepatocyte-Phase MR Imaging in Patients with Child-Pugh Class A Disease. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  9. Motosugi U, Ichikawa T, Yamaguchi H, Shimizu M, Furukawa T, Araki T:Imaging Studies of Intraductal Tubulopapillary Neoplasms of the Pancreas: A Newly Categorized Pancreas Tumor by WHO Classification. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  10. Sano K, Ichikawa T, Motosugi U, Morisaka H, Sou H, Muhi A, Araki T:Visual Analog Scale (VAS) Evalution of Diagnostic Confidence and Fatigue Degree: Influence of Iodine Dose for Adominal Contrast-enhanced MDCT in the Daily Work. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  11. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Sou H, Muhi A, Araki T:Intravoxel Incoherent Motion Diffusion-weighted Imaging for Distinguishing between Malignant and Benign Hepatic Focal Liver Lesions. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  12. Muhi A, Sano K, Motosugi U, Ichikawa T, Morisaka H, Onohara K, Araki T:The Outcome of Hypovascular and Hypointense Nodules on Hepatocyte-phase Gadoxetic Acid-enhanced Magnetic Resonance Imaging: When Does It Become a Convenional HCC? Three-year Follow-up Study. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
  13. Morisaka H, Motosugi U, Sano K, Ichikawa T, Araki T:Non-Helical, Volumetric Dual-Energy CT Imaging with Area-Detector CT Scanner for Evaluating Hypervascular Hepatocellular Carcinoma. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12-2, Chicago, USA.
  14. Ichikawa T:Workshop “Diagnosis and manegement of HCC – the role of Primovist-enhanced MRI in guiding treatment strategy”. The 5th International Forum for Liver MRI, 2011. 9.16, Munich, Germany.